Category Archives: Research

Featured Research – R. L. Nevin and E. C. Ritchie, Service-Connected Disability Claim for Chronic Neuropsychiatric Adverse Effects From Mefloquine

“In 2014, a 56-year-old nondeployed U.S. Marine Corps veteran submitted a claim to the VA for disabling conditions. The veteran alleged these conditions were due to his exposure to mefloquine while in military service more than 2 decades earlier. The … Continue reading

Posted in Clinical Drug Trials, Our Stories, Research | Tagged , , , , , , , | Leave a comment

Stuart McCarthy – Disband the Army Malaria Institute and Prohibit Drug Trials on Australian Troops

The anti-malarial drug trial scandal that has embroiled the Australian Defence Force for the last two years simply won’t go away, despite the government’s best efforts to whitewash the controversy with a flawed “military justice” inquiry. There are growing calls … Continue reading

Posted in Advocacy, Clinical Drug Trials, Research | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Nebojsa ‘Vic’ Zlatanovic – Congress, Peanuts & Mefloquine

In a November 9th letter to the Pentagon and the Department of Veterans Affairs, Senator Bob Menendez (D-NJ) urged them to create a registry to monitor the long-term health of veterans who took mefloquine, a once-weekly anti-malarial that the Food … Continue reading

Posted in Advocacy, Media, Research | Tagged , , , , , , | Leave a comment

PTSD as a “Diagnosis of Convenience”: Mefloquine, Tafenoquine and the Prevalence of Neuropsychiatric Disorders in ADF Veterans of East Timor and Bougainville

One of the problems that has perplexed many Australian government officials and veterans advocates in recent years is the disproportionately high number of Australian Defence Force (ADF) East Timor veterans who have been diagnosed with post-traumatic stress disorder (PTSD). PTSD is … Continue reading

Posted in Advocacy, Clinical Drug Trials, Research | Tagged , , , , , , , , , , , , , | 3 Comments

Scientific Misconduct in the Australian Army Malaria Institute’s Clinical Trials of Tafenoquine – Part 2

Part 1 of this series provided some background to the Australian Army Malaria Institute’s (AMI) tafenoquine trials in 1999-2002, including an outline of the preceding trials and more recent laboratory studies relating to the drug’s efficacy and toxicity. This post … Continue reading

Posted in Advocacy, Clinical Drug Trials, Research | Tagged , , , , , | Leave a comment

Australian Army Malaria Institute Trial of Tafenoquine with 3 RAR Personnel in Timor Leste, February 2000

During the period 1999-2001 the Australian Army Malaria Institute (AMI) conducted a series of tafenoquine drug trials involving Australian Defence Force (ADF) personnel deployed on peacekeeping operations. The published trial reports include those involving members of the Peace Monitoring Group … Continue reading

Posted in Advocacy, Clinical Drug Trials, Research | Tagged , , , , , , , , | 4 Comments

Australian Government Gives $10 million in “Foreign Aid” to Consortium Involved in the Development of a Neurotoxic Drug, While Refusing to Help Affected Veterans

  Since 2015 the Australian Army Malaria Institute (AMI) has been embroiled in a scandal over its testing of the neurotoxic anti-malarial drugs mefloquine and tafenoquine on military personnel deployed on peacekeeping operations in Bougainville and Timor Leste from 1999 to 2002. … Continue reading

Posted in Clinical Drug Trials, Media, Research | Tagged , , , , , , , | 3 Comments

Featured Research – J. Livezey et al, Prolonged Neuropsychiatric Symptoms in a Military Service Member Exposed to Mefloquine

“A 32-year-old male developed neuropsychiatric symptoms 2 weeks after starting mefloquine 250 mg/week for malaria prophylaxis. He continued to take the medication for the next 4 months. Initial symptoms included vivid dreams and anxiety, as well as balance problems. These symptoms persisted and … Continue reading

Posted in Research | Tagged , , , , , , , | Leave a comment

British Parliamentary Inquiry: “Lariam Should be ‘Drug of Last Resort’ for Troops”

  Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee, in its report on the MoD’s use of the drug. Report: An acceptable risk? The use … Continue reading

Posted in Advocacy, Research | Tagged , , , , , , , , , | Leave a comment

Scientific Misconduct in the Australian Army Malaria Institute’s Clinical Trials of Tafenoquine – Part 1

The New Mefloquine? Mefloquine is now well known to be neurotoxic, one of several synthetic quinolines able to cause acute psychotic reactions and/or a chronic central nervous system (CNS) toxicity syndrome in a significant proportion of people given these drugs … Continue reading

Posted in Clinical Drug Trials, Media, Research | Tagged , , , , , , , , , | 2 Comments